hackint0sh/temp-data huggingface dataset:
protocolSection identificationModule nctId: NCT06327854, orgStudyIdInfo id: NUOROS (PI: M Briguglio), secondaryIdInfos id: L4175, type: OTHER_GRANT, domain: Italian Ministry of Health, briefTitle: NUtrition and ORal Health in Orthopaedic Surgery, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-03-18, primaryCompletionDateStruct date: 2024-03-22, completionDateStruct date: 2024-12-10, studyFirstPostDateStruct date: 2024-03-25, lastUpdatePostDateStruct date: 2024-03-25, sponsorCollaboratorsModule leadSponsor name: I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio, class: OTHER, descriptionModule briefSummary: This prospective observational study evaluates the relationship between the objective oral health status and the patient reported diet in 64 adult patients undergoing elective major orthopaedic surgery (hip, knee, or spine surgery)., conditionsModule conditions: Orthopedic Disorder, conditions: Metabolism and Nutrition Disorder, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: PROSPECTIVE, enrollmentInfo count: 64, type: ESTIMATED, outcomesModule primaryOutcomes measure: Association between pre-operative oral health and diet, eligibilityModule sex: ALL, minimumAge: 55 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio, status: RECRUITING, city: Milan, country: Italy, contacts name: Elena Cittera, role: CONTACT, phone: 00390283502224, email: elena.cittera@grupposandonato.it, contacts name: Matteo Briguglio, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 45.46427, lon: 9.18951, hasResults: False
protocolSection identificationModule nctId: NCT06327841, orgStudyIdInfo id: EK 1117/2022, briefTitle: Plaque Reduction Sesame Oil, statusModule overallStatus: COMPLETED, startDateStruct date: 2022-06-21, primaryCompletionDateStruct date: 2022-08-18, completionDateStruct date: 2022-08-18, studyFirstPostDateStruct date: 2024-03-25, lastUpdatePostDateStruct date: 2024-03-25, sponsorCollaboratorsModule leadSponsor name: Medical University Innsbruck, class: OTHER, descriptionModule briefSummary: The goal of this clinical trials to learn about potential additives in reducing dental plaque. The main questions it aims to answer is:• is there a difference in the plaque reducing effect of oil pulling with sesame oil compared to rinsing with distilled water? Participants will rinse with 15 ml of their allocated liquid for 15 min every morning for 8 weeks.Researchers will compare sesame oil against distilled water to see if there is a difference in the plaque reducing effect., conditionsModule conditions: Dental Plaque, conditions: Gingivitis, conditions: Oral Microbial Colonization, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: DOUBLE, whoMasked: INVESTIGATOR, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 40, type: ACTUAL, armsInterventionsModule interventions name: sesame oil, interventions name: distilled water, outcomesModule primaryOutcomes measure: Rustogi Modified Navy Plaque Index (RMNPI), secondaryOutcomes measure: Gingival Index (GI), secondaryOutcomes measure: microbial analysis, secondaryOutcomes measure: Oral Health Impact Profile (OHIP), secondaryOutcomes measure: Interview halitosis, xerostomia, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 99 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Medical University, city: Innsbruck, state: Tyrol, zip: 6020, country: Austria, geoPoint lat: 47.26266, lon: 11.39454, hasResults: False
protocolSection identificationModule nctId: NCT06327828, orgStudyIdInfo id: 32-663, briefTitle: Methimazole in Graves' Disease - a Randomised Controlled Trial Comparing the Computer-aided Treatment DigiThy Versus Usual Care, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04-01, primaryCompletionDateStruct date: 2026-10-01, completionDateStruct date: 2026-10-01, studyFirstPostDateStruct date: 2024-03-25, lastUpdatePostDateStruct date: 2024-03-25, sponsorCollaboratorsModule leadSponsor name: Medical University of Graz, class: OTHER, collaborators name: Graz University of Technology, descriptionModule briefSummary: The goal of this clinical trial is to compare two methods of guiding methimazole therapy in patients with Graves' disease: methimazole dose adjustments based on a new semi-automated computer-guided treatment (based on a mathematical model) or based on the treating physician's decision (i.e. usual care). The main question it aims to answer is whether semi-automated computer-guided treatment is not inferior to usual care in terms of safety, the time it takes to achieve euthyroidism and the methimazole dose required., conditionsModule conditions: Graves Disease, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 52, type: ESTIMATED, armsInterventionsModule interventions name: Semi-automated computer-aided treatment (Digital Thyroid, DigiThy), interventions name: Usual care, outcomesModule primaryOutcomes measure: The primary aim is to compare semi-automated computer-guided treatment with usual care in terms of their performance indices, secondaryOutcomes measure: Comparison in terms of dosing and penalties, secondaryOutcomes measure: Comparison based on free thyroxine (fT4) target range, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Medical University of Graz, city: Graz, zip: 8044, country: Austria, contacts name: Verena Theiler-Schwetz, MD, PhD, role: CONTACT, geoPoint lat: 47.06667, lon: 15.45, hasResults: False
protocolSection identificationModule nctId: NCT06327802, orgStudyIdInfo id: 20240104, briefTitle: Improving the Well-being of Caregivers of Cystic Fibrosis Patients During Physiotherapy Treatment, acronym: MucoZar, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04-01, primaryCompletionDateStruct date: 2024-12-31, completionDateStruct date: 2025-07-31, studyFirstPostDateStruct date: 2024-03-25, lastUpdatePostDateStruct date: 2024-03-25, sponsorCollaboratorsModule leadSponsor name: Pole Sante Grace de Dieu, class: OTHER, descriptionModule briefSummary: The main objective of the study is to determine the impact of cystic fibrosis affecting a child on the parents' quality of life, their possible anxiety and depressive symptoms, their general fatigue and the feeling of burden in these caregivers., conditionsModule conditions: Cystic Fibrosis, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: PROSPECTIVE, enrollmentInfo count: 360, type: ESTIMATED, armsInterventionsModule interventions name: Questionnaire, outcomesModule primaryOutcomes measure: Zarit Burden Interview, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: PSLA GDD, city: Caen, zip: 14000, country: France, geoPoint lat: 49.18585, lon: -0.35912, hasResults: False
protocolSection identificationModule nctId: NCT06327789, orgStudyIdInfo id: ZBEU-MS, briefTitle: Trunk Control and Disability in Persons With Multiple Sclerosis, statusModule overallStatus: COMPLETED, startDateStruct date: 2021-12-21, primaryCompletionDateStruct date: 2021-12-25, completionDateStruct date: 2022-02-21, studyFirstPostDateStruct date: 2024-03-25, lastUpdatePostDateStruct date: 2024-03-25, sponsorCollaboratorsModule leadSponsor name: Zonguldak Bulent Ecevit University, class: OTHER, descriptionModule briefSummary: This study aims to investigate the relationship between physical disability and trunk control, balance, and pedobarographic parameters in persons with Relapsing Remitting Multiple Sclerosis (RRMS) who have a low Expanded Disability Status Scale (EDSS) score. Twenty-three RRMS patients with an age range of 18-50 years, EDSS score ≤ 3 were included in this study. The patients' level of disability (EDSS), trunk control )Trunk Impairment Scale - TIS), lower extremity functionality (Timed 25-Foot Walk Test - T25FW), upper extremity functionality (Nine Hole Peg Test- 9HPT), balance (Biodex Balance System) and gait (Zebris® FDM 2) were evaluated., conditionsModule conditions: Multiple Sclerosis, designModule studyType: OBSERVATIONAL, designInfo observationalModel: CASE_ONLY, timePerspective: PROSPECTIVE, enrollmentInfo count: 23, type: ACTUAL, armsInterventionsModule, outcomesModule primaryOutcomes measure: Expanded Disability Status Scale (EDSS), primaryOutcomes measure: Trunk Impairment Scale (TIS), primaryOutcomes measure: Biodex Balance System (BBS) (MedicalSystems, Shirley, NY, USA), primaryOutcomes measure: Step Length (cm), primaryOutcomes measure: Stride Length (cm), primaryOutcomes measure: Step Width (cm), primaryOutcomes measure: Cadence (steps/min), primaryOutcomes measure: Velocity (m/s), primaryOutcomes measure: Step time (s), primaryOutcomes measure: Stride time (s), primaryOutcomes measure: Timed 25-Foot Walk Test (T25FW), primaryOutcomes measure: Nine-Hole Peg Test (9HPT), eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 50 Years, stdAges: ADULT, contactsLocationsModule locations facility: Zonguldak Bülent Ecevit University, city: Zonguldak, country: Turkey, geoPoint lat: 41.45139, lon: 31.79305, hasResults: False
protocolSection identificationModule nctId: NCT06327776, orgStudyIdInfo id: 21/709, briefTitle: New Protein Biomarkers and Technology for Improving Diagnosis and Outcome Prediction in Mild TBI, statusModule overallStatus: RECRUITING, startDateStruct date: 2022-03-04, primaryCompletionDateStruct date: 2025-07-31, completionDateStruct date: 2025-12-31, studyFirstPostDateStruct date: 2024-03-25, lastUpdatePostDateStruct date: 2024-03-25, sponsorCollaboratorsModule leadSponsor name: Hospital Universitario 12 de Octubre, class: OTHER, descriptionModule briefSummary: Mild traumatic brain injury(mTBI) is a common cause of consultation to the emergency rooms worldwide and is the most common form of traumatic brain injury. Though classified as mild, as many as 40% of patients suffering mTBI do not make complete recoveries or present persistent symptoms. The present study is intended to determine long term outcome of patients suffering mTBI and to establish new prognostic models with the use of serum and saliva based biomarkers. For this purpose this study will not exclude patients regarding their comorbidities., conditionsModule conditions: Mild Traumatic Brain Injury, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: PROSPECTIVE, enrollmentInfo count: 1000, type: ESTIMATED, armsInterventionsModule interventions name: Serum and saliva biomarkers, outcomesModule primaryOutcomes measure: Biomarkers diagnostic performance, secondaryOutcomes measure: Determination of the potential of the biomarkers in predicting neurological symptoms after TBI, secondaryOutcomes measure: Determination of the potential of the biomarkers in predicting neurological outcome assessed by the Extended Glasgow Outcome Score (GOSE) after TBI, secondaryOutcomes measure: Determination of the potential of the biomarkers in predicting quality of life assessed by Qolibri-OS after TBI, secondaryOutcomes measure: Determination of the potential of the biomarkers in predicting quality of life assessed by EQ-5D-5L after TBI, secondaryOutcomes measure: Determination of the potential of the biomarkers in predicting quality of sleep assessed by the Epworth and Pittsburgh Scales, eligibilityModule sex: ALL, minimumAge: 15 Years, stdAges: CHILD, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Hospital Universitario 12 de Octubre, status: RECRUITING, city: Madrid, zip: 28041, country: Spain, contacts name: Alfonso Lagares, MD, PhD, role: CONTACT, phone: +34917792389, email: alfonso.lagares@salud.madrid.org, geoPoint lat: 40.4165, lon: -3.70256, hasResults: False
protocolSection identificationModule nctId: NCT06327763, orgStudyIdInfo id: Ilioinguinal Neurectomy, briefTitle: Prophylactic Ilioinguinal Neurectomy During Open Tension-Free Inguinal Hernia Repair, statusModule overallStatus: COMPLETED, startDateStruct date: 2022-01-01, primaryCompletionDateStruct date: 2023-06-01, completionDateStruct date: 2023-06-01, studyFirstPostDateStruct date: 2024-03-25, lastUpdatePostDateStruct date: 2024-03-25, sponsorCollaboratorsModule leadSponsor name: Zagazig University, class: OTHER_GOV, descriptionModule briefSummary: postoperative chronic inguinal pain is a common postoperative complication after open inguinal hernia repair.Chronic inguinal pain is a common complication following open inguinal hernia repair. Ilioinguinal nerve entrapment is a common cause of this chronic pain which may adversely affect the patients' life. Ilioinguinal neurectomy seems to be beneficial in preventing such pain, but it carries the risk for numbness and hypoesthesia., conditionsModule conditions: Ilioinguinal Nerve Section, conditions: Pain Prevention, conditions: Hernioplasty, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: PREVENTION, maskingInfo masking: NONE, enrollmentInfo count: 196, type: ACTUAL, armsInterventionsModule interventions name: ilioinguinal nerve section, outcomesModule primaryOutcomes measure: detect postoperative pain using short form inguinal pain questionnaire, eligibilityModule sex: MALE, minimumAge: 16 Years, maximumAge: 80 Years, stdAges: CHILD, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: yasmine Hegab, city: Zagazig, zip: 7120730, country: Egypt, geoPoint lat: 30.58768, lon: 31.502, hasResults: False
protocolSection identificationModule nctId: NCT06327737, orgStudyIdInfo id: AKDENIZ-KAEK-916, briefTitle: Diabetic Ketoacidosis Diagnosis and Management, statusModule overallStatus: COMPLETED, startDateStruct date: 2020-12-15, primaryCompletionDateStruct date: 2022-11-15, completionDateStruct date: 2023-03-15, studyFirstPostDateStruct date: 2024-03-25, lastUpdatePostDateStruct date: 2024-03-25, sponsorCollaboratorsModule leadSponsor name: Akdeniz University, class: OTHER, collaborators name: Ceren Kahraman, descriptionModule briefSummary: This is the first and only study conducted on the use of capnography in children diagnosed with DKA to evaluate the initial clinical grading of DKA, monitor clinical improvement, and predict complications such as brain edema., conditionsModule conditions: Metabolic Acidosis, conditions: Diabetic Ketoacidosis, conditions: Brain Edema, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: PROSPECTIVE, enrollmentInfo count: 55, type: ACTUAL, armsInterventionsModule interventions name: Capnography, outcomesModule primaryOutcomes measure: Correlation between PCO2 and EtCO2, primaryOutcomes measure: Correlation between Integrated Pulmonary Index and degree of acidosis, primaryOutcomes measure: Prediction of cerebral edema with Integrated Pulmonary Index, eligibilityModule sex: ALL, minimumAge: 15 Days, maximumAge: 18 Years, stdAges: CHILD, stdAges: ADULT, contactsLocationsModule locations facility: Akdeniz University, city: Antalya, country: Turkey, geoPoint lat: 36.90812, lon: 30.69556, hasResults: False
protocolSection identificationModule nctId: NCT06327711, orgStudyIdInfo id: BL77, briefTitle: Benefits of Nutritional Ingredients for Type 2 Diabetes, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04, primaryCompletionDateStruct date: 2025-03, completionDateStruct date: 2025-03, studyFirstPostDateStruct date: 2024-03-25, lastUpdatePostDateStruct date: 2024-03-25, sponsorCollaboratorsModule leadSponsor name: Abbott Nutrition, class: INDUSTRY, descriptionModule briefSummary: This is a prospective randomized, double-blinded, parallel design study to evaluate the benefits of long-term consumption of two experimental blends of liquid supplements., conditionsModule conditions: Diabetes type2, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: 2 groups, non-crossover, primaryPurpose: OTHER, maskingInfo masking: QUADRUPLE, whoMasked: PARTICIPANT, whoMasked: CARE_PROVIDER, whoMasked: INVESTIGATOR, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 114, type: ESTIMATED, armsInterventionsModule interventions name: Control: CHO Blend, interventions name: Experimental: CHO Blend plus AN100, outcomesModule primaryOutcomes measure: Matsuda Index, primaryOutcomes measure: Fasted Glucose, primaryOutcomes measure: Fasted Insulin, secondaryOutcomes measure: Body Weight, secondaryOutcomes measure: Body Composition Measurements, secondaryOutcomes measure: Continuous Glucose Monitoring, secondaryOutcomes measure: Glycated Hemoglobin, secondaryOutcomes measure: Resting Energy Expenditure (REE), secondaryOutcomes measure: Microbiome - Fecal, secondaryOutcomes measure: Microbiome - Saliva, secondaryOutcomes measure: Waist Circumference, secondaryOutcomes measure: Hip Circumference, secondaryOutcomes measure: Conicity Index, otherOutcomes measure: Blood Pressure, otherOutcomes measure: Accelerometry Data, otherOutcomes measure: Diabetes Distress Scale, otherOutcomes measure: Dietary Intake, otherOutcomes measure: Blood biomarkers - inflammation, otherOutcomes measure: Urine biomarkers - inflammation, eligibilityModule sex: ALL, minimumAge: 40 Years, maximumAge: 65 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06327698, orgStudyIdInfo id: AK104-IIT-C-S-0010, briefTitle: Cadonilimab in Combination With Anlotinib in the Treatment of Locally Progressive or Metastatic Melanoma With First-Line Therapy Failure, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-05-15, primaryCompletionDateStruct date: 2026-05-31, completionDateStruct date: 2027-05-31, studyFirstPostDateStruct date: 2024-03-25, lastUpdatePostDateStruct date: 2024-03-25, sponsorCollaboratorsModule leadSponsor name: Hunan Cancer Hospital, class: OTHER, descriptionModule briefSummary: This study is an open-label, multicenter, single-arm Phase II clinical study to evaluate the effectiveness of cadonilimab (AK104) in combination with anlotinib in the treatment of locally advanced or metastatic melanoma., conditionsModule conditions: Melanoma, designModule studyType: INTERVENTIONAL, phases: PHASE2, designInfo allocation: NA, interventionModel: SINGLE_GROUP, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 30, type: ESTIMATED, armsInterventionsModule interventions name: Cadonilimab, interventions name: anlotinib, outcomesModule primaryOutcomes measure: Response Rate, secondaryOutcomes measure: Progression-free Survival (PFS), secondaryOutcomes measure: Disease Control Rate (DCR), secondaryOutcomes measure: Safety and tolerability, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 75 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06327659, orgStudyIdInfo id: Thrombectomy by 50 ml syringe, briefTitle: Efficacy of Using 50 ml Syringe Manual Thrombectomy Catheter in Primary PCI With Heavy Thrombus Burden, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04-01, primaryCompletionDateStruct date: 2025-01-01, completionDateStruct date: 2025-01-01, studyFirstPostDateStruct date: 2024-03-25, lastUpdatePostDateStruct date: 2024-03-26, sponsorCollaboratorsModule leadSponsor name: Helwan University, class: OTHER, descriptionModule briefSummary: In high thrombus burden subgroup of Acute STEMI, manual aspiration thrombectomy was associated with reduced cardiovascular death but increased stroke or transient ischemic attack. The role of aspiration thrombectomy is still a matter of active debate. Manual aspiration suffers from decreasing aspiration force as the syringe fills with fluid and requires the operator to exchange syringes during the procedure to maintain suction., conditionsModule conditions: STEMI - ST Elevation Myocardial Infarction, conditions: Thrombosis Cardiac, designModule studyType: INTERVENTIONAL, phases: PHASE3, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: SINGLE, whoMasked: PARTICIPANT, enrollmentInfo count: 88, type: ESTIMATED, armsInterventionsModule interventions name: 30 mL syringe manual thrombectomy catheter, interventions name: 50 mL syringe manual thrombectomy catheter, outcomesModule primaryOutcomes measure: TIMI flow grade after PCI, primaryOutcomes measure: MBG after PCI, secondaryOutcomes measure: Composite rate of occurrence of MACE, secondaryOutcomes measure: Rate of cardiovascular death, secondaryOutcomes measure: Rate of recurrent myocardial infarction, secondaryOutcomes measure: Rate of stroke, secondaryOutcomes measure: Rate of cardiogenic shock, secondaryOutcomes measure: Rate of NYHA IV heart failure, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Badr University Hospital, city: Badr, state: Cairo, country: Egypt, contacts name: Arafa Gomaa, MD, role: CONTACT, contacts name: Arafa Gomaa, MD, role: PRINCIPAL_INVESTIGATOR, hasResults: False
protocolSection identificationModule nctId: NCT06327633, orgStudyIdInfo id: ZZ2024, briefTitle: Effects of Olfactory Training on the Brain Function in T2DM Patients With Mild Cognitive Impairment, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-01-01, primaryCompletionDateStruct date: 2024-08-01, completionDateStruct date: 2024-08-01, studyFirstPostDateStruct date: 2024-03-25, lastUpdatePostDateStruct date: 2024-03-26, sponsorCollaboratorsModule leadSponsor name: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, class: OTHER, descriptionModule briefSummary: This is a pilot, prospective, randomized, open label, parallel, 4-month study to explore and evaluate the therapeutic effects of olfactory training on the cognitive function, olfactory function, and odor-induced brain activation in T2DM patients with mild cognitive impairment (MCI)., conditionsModule conditions: Type 2 Diabetes Mellitus, conditions: Mild Cognitive Impairment, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 40, type: ESTIMATED, armsInterventionsModule interventions name: Olfactory Training, outcomesModule primaryOutcomes measure: Change of olfactory brain activation by fMRI, secondaryOutcomes measure: Change of cognitive function, secondaryOutcomes measure: Olfactory threshold test, secondaryOutcomes measure: Change of metabolism, eligibilityModule sex: ALL, minimumAge: 40 Years, maximumAge: 75 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Division of Endocrinology, the Affiliated Drum Tower Hospital of Nanjing University, status: RECRUITING, city: Nanjing, state: Jiangsu, zip: 210008, country: China, contacts name: Yan Bi, MD, PhD, role: CONTACT, phone: 86-25-83-105302, email: biyan@nju.edu.cn, contacts name: YAN BI, MD, PhD, role: PRINCIPAL_INVESTIGATOR, contacts name: ZHOU ZHANG, MD, PhD, role: SUB_INVESTIGATOR, geoPoint lat: 32.06167, lon: 118.77778, hasResults: False